December 21, 2004 -- The NIH said today that long-term exposure to Aleve (Naproxen), a product from Bayer, was associated with increased risk of stroke and cardiovascular infarction, but that Pfizer’s Celebrex showed no similar problems. We argue that total safety isn’t possible, but that the best pain-killing drug has been around for a century, and attempts to improve on it haven’t been successful...
